Longbio Pharma & Dajin Debut on SEHK
05 Jun 2026
US$ 20.00
Longbio Pharma (Suzhou) Co Ltd (Longbio), backed by Highlight Capital, Qiming Venture Partners and Oriental Fortune...
Related Publications
BGH Capital (BGH) joined the contest for ASX-listed EQT Holdings Ltd (EQTH), offering A$24.75 (US$17.7) per share, 0.8%...
TPG Inc has sold part of its stake in the India-listed Aster DM Quality Care Ltd (Aster QC) and clocked 44.5 bn rupees...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.